Maryland - Session 2026
Title: Health Insurance - Prescriptions for Gender-Affirming Care and Hormone Therapy - Coverage and Dispensing Requirements
Requiring insurers, nonprofit health service plans, and health maintenance organizations to provide coverage for a certain supply of prescription drugs used for gender-affirming care, hormone therapy, or reproductive health in certain circumstances; and altering the amount of certain prescription drugs that a pharmacist is allowed to dispense on or after January 1, 2027.
| Date | Event | Detail |
|---|---|---|
| 2026-02-13 | Introduced | Bill introduced |
| 2026-02-13 | Status | introduced |
| 2026-04-04 | Latest Action | In the House - Hearing 3/13 at 1:30 p.m. |
| Bill | Title | Status |
|---|---|---|
| HB 1076 | Higher Education Institutions - Over-the-Counter Contraception - Access and Reporting | passed_lower |
| HB 1131 | Public Health - Pregnancy Loss - Prohibited Actions (Pregnancy Outcome Protection Act) | introduced |
| HB 1159 | Public Health and Health Insurance - Access to Abortion Care - Reporting Requirements | introduced |
| HB 1281 | Health - Abortion - Ultrasound and Wait Time | introduced |
| HB 1401 | Public Health - Abortion - Informed Consent | introduced |
| HB 1451 | Public Health - Women's Health Care Data - Report | introduced |
| HB 158 | Maryland Medical Assistance Program - Maternal Health Monitoring Pilot Program | introduced |
| HB 209 | Health Care Providers - Assisted Reproductive Treatment - Informed Consent and Fraud | introduced |